All In Biotech

Drug Trial Radar · NCT00015899

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors

Last checked: Nov 19, 2026Latest source record: Oct 14, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

53

Actual

Start

Jan 2002

Primary completion

Sep 2005

Study completion Mar 2007

Sponsor

Lead sponsor
Pediatric Brain Tumor ConsortiumResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: SCH 66336 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of SCH 66336 in treating children with recurrent or progressive brain tumors.

Conditions

  • Brain and Central Nervous System Tumors

Interventions

  • lonafarnibDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Toxicities of SCH 66336 in children and adolescents with refractory CNS cancers
  2. Maximum tolerated dose of SCH 66336Time frame: Four weeks
  3. Pharmacokinetics of SCH 66336

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • UCSF Comprehensive Cancer Center

    San Francisco, California

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Boston, Massachusetts

  • Duke Comprehensive Cancer Center

    Durham, North Carolina

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • Texas Children's Cancer Center

    Houston, Texas

  • Children's Hospital and Regional Medical Center - Seattle

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.